Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | FKB238 |
Synonyms | |
Therapy Description |
FKB238 is a biosimilar to Avastin (bevacizumab), which is a VEGFA targeted antibody (J Clin Oncol 35, 2017 (suppl; abstr e14007)). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
FKB238 | HD204|BP102|SCT501 | VEGFA Antibody 4 | FKB238 is a biosimilar to Avastin (bevacizumab), which is a VEGFA targeted antibody (J Clin Oncol 35, 2017 (suppl; abstr e14007)). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|